open access

Vol 13, No 2 (2018)
Review Papers
Published online: 2018-05-30
Get Citation

Arterial stiffness assessment in patients with chronic kidney disease

Konrad Rekucki, Marcin Madziarski, Aleksandra Gajek, Agnieszka Sławuta, Katarzyna Madziarska
DOI: 10.5603/FC.2018.0026
·
Folia Cardiologica 2018;13(2):144-149.

open access

Vol 13, No 2 (2018)
Review Papers
Published online: 2018-05-30

Abstract

Cardiovascular diseases are the main cause of death among patients with chronic kidney disease. Classic and disease-specific cardiovascular risk factors are observed in this group of patients.

Recently, arterial stiffness has been paid more attention to as a cardiovascular risk factor. High-resolution echo-tracking is a direct and non-invasive ultrasound method of local arterial stiffness evaluation. New publications show that indices of local arterial stiffness, such as stiffness parameter beta, are predictors of cardiovascular mortality. Evaluation of local arterial stiffness can take a prominent place in cardiovascular risk assessment due to limitations of standard diagnostic methods present in chronic kidney disease. Further studies on high-resolution echo-tracking are essential to establish the role of this method in evaluation of chronic kidney disease patients.

Abstract

Cardiovascular diseases are the main cause of death among patients with chronic kidney disease. Classic and disease-specific cardiovascular risk factors are observed in this group of patients.

Recently, arterial stiffness has been paid more attention to as a cardiovascular risk factor. High-resolution echo-tracking is a direct and non-invasive ultrasound method of local arterial stiffness evaluation. New publications show that indices of local arterial stiffness, such as stiffness parameter beta, are predictors of cardiovascular mortality. Evaluation of local arterial stiffness can take a prominent place in cardiovascular risk assessment due to limitations of standard diagnostic methods present in chronic kidney disease. Further studies on high-resolution echo-tracking are essential to establish the role of this method in evaluation of chronic kidney disease patients.

Get Citation

Keywords

arterial stiffness, echo-tracking, chronic kidney disease

About this article
Title

Arterial stiffness assessment in patients with chronic kidney disease

Journal

Folia Cardiologica

Issue

Vol 13, No 2 (2018)

Pages

144-149

Published online

2018-05-30

DOI

10.5603/FC.2018.0026

Bibliographic record

Folia Cardiologica 2018;13(2):144-149.

Keywords

arterial stiffness
echo-tracking
chronic kidney disease

Authors

Konrad Rekucki
Marcin Madziarski
Aleksandra Gajek
Agnieszka Sławuta
Katarzyna Madziarska

References (29)
  1. Mancia G, Fagard R, Narkiewicz K, et al. Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology, ESH/ESC Task Force for the Management of Arterial Hypertension, Task Force Members, Task Force for the management of arterial hypertension of the European Society of Hypertension, Task Force for the management of arterial hypertension of the European Society of Cardiology. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28): 2159–2219.
  2. Blacher J, Safar ME, Pannier B, et al. Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr Opin Nephrol Hypertens. 2002; 11(6): 629–634.
  3. Karras A, Haymann JP, Bozec E, et al. Nephro Test Study Group. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension. 2012; 60(6): 1451–1457.
  4. Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27(21): 2588–2605.
  5. DeLoach SS, Townsend RR. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol. 2008; 3(1): 184–192.
  6. Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001; 103(7): 987–992.
  7. Cieślik-Guerra U. Metody pomiaru sztywności tętnic. Nadciśnienie Tętnicze. 2011; 15: 42–48.
  8. Jaroch J, Rzyczkowska B, Bociąga Z, et al. Relationship of carotid arterial functional and structural changes to left atrial volume in untreated hypertension. Acta Cardiol. 2016; 71(2): 227–233.
  9. Hirai T, Sasayama S, Kawasaki T, et al. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation. 1989; 80(1): 78–86.
  10. Yu ZX, Wang XZ, Guo RJ, et al. Comparison of ultrasound echo-tracking technology and pulse wave velocity for measuring carotid elasticity among hemodialysis patients. Hemodial Int. 2013; 17(1): 19–23.
  11. Sato M, Ogawa T, Otsuka K, et al. Stiffness parameter β as a predictor of the 4-year all-cause mortality of chronic hemodialysis patients. Clin Exp Nephrol. 2013; 17(2): 268–274.
  12. Shoji T, Maekawa K, Emoto M, et al. Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients. Atherosclerosis. 2010; 210(1): 145–149.
  13. Matsushita K, van der Velde M, Astor BC, et al. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375(9731): 2073–2081.
  14. KGIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Nephrol Dial. 2017; 19(1): 22–206.
  15. Rao MV, Qiu Y, Wang C, et al. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am J Kidney Dis. 2008; 51(4 Suppl 2): S30–S37.
  16. Yerkey MW, Kernis SJ, Franklin BA, et al. Renal dysfunction and acceleration of coronary disease. Heart. 2004; 90(8): 961–966.
  17. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13): 1296–1305.
  18. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004; 164(6): 659–663.
  19. Peralta CA, Katz R, Sarnak MJ, et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol. 2011; 22(1): 147–155.
  20. Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011; 305(11): 1119–1127.
  21. Guérin AP, Pannier B, Métivier F, et al. Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2008; 17(6): 635–641.
  22. London GM, Guérin AP, Verbeke FH, et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007; 18(2): 613–620.
  23. Raggi P, Bellasi A, Ferramosca E, et al. Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension. 2007; 49(6): 1278–1284.
  24. Ogawa T, Shimada M, Ishida H, et al. Relation of stiffness parameter beta to carotid arteriosclerosis and silent cerebral infarction in patients on chronic hemodialysis. Int Urol Nephrol. 2009; 41(3): 739–745.
  25. Paini A, Boutouyrie P, Calvet D, et al. Carotid and aortic stiffness: determinants of discrepancies. Hypertension. 2006; 47(3): 371–376.
  26. Mitchell GF, Hwang SJ, Larson MG, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010; 121(4): 505–511.
  27. Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011; 80(6): 572–586.
  28. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda 2010.
  29. Charytan DM, Kuntz RE. Risks of coronary artery bypass surgery in dialysis-dependent patients — analysis of the 2001 National Inpatient Sample. Nephrol Dial Transplant. 2007; 22(6): 1665–1671.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl